OpGen Price to Free Cash Flow Ratio 2014-2024 | OPGN

OpGen price to free cash flow ratio from 2014 to 2024. Price to free cash flow ratio can be defined as

OpGen Price to Free Cash Flow Ratio 2014-2024 | OPGN

OpGen price to free cash flow ratio from 2014 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$121.5B
Cencora (COR)$44.3B
ICON (ICLR)$23.6B
DiDi Global (DIDIY)$23.3B
Avantor (AVTR)$17.6B
Natera (NTRA)$15.5B
Revvity (RVTY)$15.5B
Viatris (VTRS)$13.8B
CochLear (CHEOY)$12.8B
Solventum (SOLV)$11.7B
Medpace Holdings (MEDP)$10.3B
Charles River Laboratories (CRL)$10.2B
Sonic Healthcare (SKHHY)$9.1B
Doximity (DOCS)$8B
HealthEquity (HQY)$7B
Bausch + Lomb (BLCO)$6.7B
PACS (PACS)$6B
Organon (OGN)$4.9B
Life Times (LTH)$4.8B
Sotera Health (SHC)$4.7B
Surgery Partners (SGRY)$4.1B
Concentras Parent (CON)$2.8B
Ardent Health Partners (ARDT)$2.6B
GoodRx Holdings (GDRX)$2.6B
BrightSpring Health Services (BTSG)$2.6B
Alignment Healthcare (ALHC)$2.2B
Premier (PINC)$2B
Ryman Healthcare (RYHTY)$2B
AMN Healthcare Services Inc (AMN)$1.6B
CareDx (CDNA)$1.6B